一款全球首创新药的诞生,往往被寄予成为重磅炸弹的期望。
但现实并非全部如此……
近日,一家在纳斯达克上市的Biote...查看全文
牛唐2019-08-16 21:39
$Nabriva Therapeutics(NBRV)$ Lefamulin将在8月19号进行审批,药效确实还不错,但Contepo在4月30日吃了CRL,股价一直下跌,此次Lefamulin获批可能性还是较大的,不过考虑到投资人对抗生素的认可度比较低(参考$Achaogen(AKAO)$ ),市场的反应大概率应该是sell on news查看全文
苏泽逸2019-04-21 08:13
$Achaogen(AKAO)$ 抗生素研发并不是一个好的赛道,Achaogen股票已从过去52周的15美元高点跌逾98%,周二收于0.16美元,该公司估值约为1000万美元。另外三家开发创新抗生素的公司Paratek、Tetraphase市场和Nabriva股价从过去52周高点分别下跌了56%、75%和56%。查看全文
$Achaogen, Inc.(AKAO)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-11-08 AccNo: 0001564590-17-022777 Size: 164 KB 网页链接
$Achaogen, Inc.(AKAO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-08 AccNo: 0001564590-17-022736 Size: 10 MB 网页链接
$Achaogen, Inc.(AKAO)$ 8-K - Current report Filed: 2017-11-08 AccNo: 0001564590-17-022717 Size: 225 KBItem 2.02: Results of Operations and Financial Condition 网页链接
$Achaogen, Inc.(AKAO)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-11-08 AccNo: 0001564590-17-022777 Size: 164 KB 网页链接
$Achaogen, Inc.(AKAO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-08 AccNo: 0001564590-17-022736 Size: 10 MB 网页链接
$Achaogen, Inc.(AKAO)$ 8-K - Current report Filed: 2017-11-08 AccNo: 0001564590-17-022717 Size: 225 KBItem 2.02: Results of Operations and Financial Condition 网页链接
$Achaogen, Inc.(AKAO)$ 美东时间 2017-11-08 盘后 披露财报,预期EPS -0.72 网页链接
$Achaogen, Inc.(AKAO)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-10-20 AccNo: 0000921895-17-002470 Size: 93 KB 网页链接
$Achaogen, Inc.(AKAO)$ CT ORDER - Confidential treatment order Filed: 2017-09-29 AccNo: 9999999997-17-009002 Size: 11 KB 网页链接
$Achaogen, Inc.(AKAO)$ 内部交易: 2017-09-26,General Counsel,LOEB GARY ,卖出,1146普通股, $15.99